DermiSphere hDRT
Pre-clinical- Indications
- Full-thickness skin loss, Dermal regeneration, Wound healing
Company intelligence / Profile preview
Fesarius Therapeutics
Brooklyn, New York, United Statesfesariustherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Fesarius Therapeutics has received FDA marketing authorization for its flagship product, DermiSphere h DRT—a collagen-based hydrogel dermal regeneration template. The product supports stable vascularized tissue regeneration and has entered commercial use in the United States following a successful technology transfer to manufacturing partner Regenity Biosciences. Clinical results highlight improved patient outcomes in full-thickness skin loss management.
- Therapeutic areas
- OtherDermatologyInfectious Diseases
- Modalities
- Hydrogel-based drug delivery therapyBiomaterial (collagen-based scaffold)Device (dermal regeneration template)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Regenity Biosciences (exclusive development/manufacturing/supply agreement for commercial production of DermiSphere h DRT)
Beyond the preview
Go deeper on Fesarius Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fesarius Therapeutics.